RAC 5.59% $1.70 race oncology ltd

Ann: Breakthrough Zantrene Heart Protection Discovery, page-54

  1. 441 Posts.
    lightbulb Created with Sketch. 674
    Did we all catch this wonderful bit of info?

    • Race has submitted a patent application addressing the combination of Zantrene
    with an anthracycline for the protection of the heart of patients. This patent (if
    granted) would provide protection of the drug combination and its clinical use
    through 2041.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
0.090(5.59%)
Mkt cap ! $289.5M
Open High Low Value Volume
$1.60 $1.76 $1.59 $142.7K 84.97K

Buyers (Bids)

No. Vol. Price($)
2 17175 $1.70
 

Sellers (Offers)

Price($) Vol. No.
$1.77 6060 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.